Evidence map›Paper›PMID 20857869›Full record

Trial reportSleep2010

Enhancing slow wave sleep with sodium oxybate reduces the behavioral and physiological impact of sleep loss.

James K Walsh, Janine M Hall-Porter, Kara S Griffin, Ehren R Dodson, Elizabeth H Forst, Denise T Curry, Rhody D Eisenstein, Paula K Schweitzer

Open access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Sleep, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
1.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 67 citations in OpenAlex.

  1. Trial
  2. Trial
  3. The critical role of sleep spindles in hippocampal-dependent memory: a pharmacology study.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2013
    Trial
  4. Trial
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Sleep, Narcolepsy, and Sodium Oxybate.Current neuropharmacology · 2022
    Article
  11. Multimodal sleep, an innovation for treating chronic insomnia: case report and literature review.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2021
    Review
  12. Article
  13. The Treatment of Sleep Dysfunction in Neurodegenerative Disorders.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2021
    Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

James K WalshSleep Medicine and Research Center, St. Luke's Hospital, Chesterfield, MO 63017, USA. james.walsh@stlukes-stl.com
Janine M Hall-Porter
Kara S Griffin
Ehren R Dodson
Elizabeth H Forst
Denise T Curry
Rhody D Eisenstein
Paula K Schweitzer
St. Luke's Hospital · USSaint Louis University · USNorthwestern University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

STUDY

objectivesTo investigate whether enhancement of slow wave sleep (SWS) with sodium oxybate reduces the impact of sleep deprivation.

designDouble-blind, parallel group, placebo-controlled design

settingSleep research laboratory

participantsFifty-eight healthy adults (28 placebo, 30 sodium oxybate), ages 18-50 years.

interventionsA 5-day protocol included 2 screening/baseline nights and days, 2 sleep deprivation nights, each followed by a 3-h daytime (08:00-11:00) sleep opportunity and a recovery night. Sodium oxybate or placebo was administered prior to each daytime sleep period. Multiple sleep latency test (MSLT), psychomotor vigilance test (PVT), Karolinska Sleepiness Scale (KSS), and Profile of Mood States were administered during waking hours. MEASUREMENTS AND

resultsDuring daytime sleep, the sodium oxybate group had more SWS, more EEG spectral power in the 1-9 Hz range, and less REM. Mean MSLT latency was longer for the sodium oxybate group on the night following the first daytime sleep period and on the day following the second day sleep period. Median PVT reaction time was faster in the sodium oxybate group following the second day sleep period. The change from baseline in SWS was positively correlated with the change in MSLT and KSS. During recovery sleep the sodium oxybate group had less TST, SWS, REM, and slow wave activity (SWA) than the placebo group.

conclusionsPharmacological enhancement of SWS with sodium oxybate resulted in a reduced response to sleep loss on measures of alertness and attention. In addition, SWS enhancement during sleep restriction appears to result in a reduced homeostatic response to sleep loss.

Indexed as

Adjuvants, AnesthesiaAdolescentAdultAttentionBody Mass IndexDouble-Blind MethodFemaleGABA AgentsHumansMaleMiddle AgedPsychomotor PerformanceSleep DeprivationSodium OxybateYoung AdultAdjuvants, AnesthesiaGABA AgentsSodium Oxybate

Identifiers

PMID20857869
PMCPMC2938863
OpenAlexW1511078671

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.